ISHEMIK INSULT RIVOJLANISHIDA KARDIOEMBOLIKANING O’RNI

Authors

  • Mahliyo A. Alisherova Toshkent davlat tibbiyot universiteti, Tibbiy radiologiya kafedrasi assistenti
  • Yoqubov Xojiakbar Toshkent davlat tibbiyot universiteti, Davolash fakulteti talabasi

Keywords:

ishemik insult, kardioembolik insult, atrialfibrillyatsiya, antikoagulyant terapiya, transezofageal exokardiografiya, qaytalanish xavfi.

Abstract

Ishemik insult butun dunyoda o'lim va nogironlikning asosiy sabablaridan biri bo'lib, uning turlari ichida kardioembolik insult alohida o'rin tutadi. Ushbu turdagi insult og'ir klinik kechish, yuqori o'lim ko'rsatkichlari va tez-tez qaytalanish tendentsiyasi bilan ajralib turadi. Markaziy Osiyo mintaqasida ishemik insult ko'rsatkichlarining yuqoriligi (132,9/100 000 aholi) muammoning mintaqaviy ahamiyatini belgilaydi. Ishemik insult rivojlanishida kardioemboliyaning ahamiyatini o‘rganish, uning klinik, diagnostik va profilaktik jihatlarini tahlil qilish hamda qaytalanish xavfini kamaytirish strategiyalarini aniqlash. Tadqiqotda zamonaviy ilmiy adabiyotlar tahlili, xalqaro epidemiologik ma'lumotlar (Global Burden of Disease, Framingham tadqiqoti) va klinik tavsiyalar o'rganilgan. Kardioembolik insult barcha ishemik insultlarning taxminan 20 foizini tashkil etadi. Atrial fibrillyatsiya asosiy etiologik omil sifatida 60 foiz hollarda aniqlanadi va insult xavfini 5 baravarga oshiradi. Diagnostik mezonlarning evolyutsiyasi natijasida bemorlarning 10-20 foizida simptomlar maksimal darajada boshlanmasligi, sistemik emboliya esa atigi 2 foiz hollarda klinik namoyon bo'lishi aniqlandi. Zamonaviy diagnostika usullari (transezofageal exokardiografiya, uzoq muddatli EKG monitoringi) kardioembolik insultni aniqlash imkoniyatlarini sezilarli oshirgan. Qaytalanish xavfini kamaytirishda antikoalyant terapiya (varfarin, DOAC) samaradorligi 65-70 foizni tashkil etadi. Kardioembolik insultni erta tashxislash va to'g'ri davolash qaytalanadigan hodisalarni oldini olish, bemorning nogironligi va sog'liqni saqlash xarajatlarini kamaytirish uchun zarurdir. Markaziy Osiyo mintaqasida diagnostika imkoniyatlarini yaxshilash va antikoagulyant terapiyadan keng foydalanish dolzarb vazifa hisoblanadi.

 

References

Li X, Zhou G, Zhou X, et al. The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: a meta-analysis of randomized controlled trials . J Neurol Sci DOI: 10.1016/j.jns.2013.06.025

Goyal A, Yusuf S. The burden of cardiovascular disease in the Indian subcontinent. Indian J Med Res. 2006;124:235–44. [PubMed] [Google Scholar]

Lipska K, Sylaja PN, Sarma PS, Thankappan KR, Kutty VR, et al. Risk factors for acute ischaemic stroke in young adults in South India. J Neurol Neurosurg Psychiatry. 2007;78:959–63. doi: 10.1136/jnnp.2006.106831. [DOI] [PMC free article] [PubMed] [Google Scholar]

Global Burden of Disease Study 2021 DOI: 10.1016/j.eclinm.2024.102758

Global, regional, and national burden of stroke and its risk factors, 1990–2021. DOI: 10.1016/S14744422(24)003697.

Caplan LR. Brain embolism. In: Caplan LR, Hurst JW, Chimowitz MI, editors. Clinical Neurocardiology. New York: Marcel Dekker; 1999. pp. 35–185. [Google Scholar]

Aring C, Merritt H. Differential diagnosis between cerebral hemorrhage and cerebral thrombosis. Arch Intern Med. 1935;56:435–56. [Google Scholar]

Whisnant J, Fitzgibbons J, Kurland L, Sayre GP. Natural history of strokein Rochester, Minnesota 1945-1954. Stroke. 1971;2:11–22. doi: 10.1161/01.str.2.1.11. [DOI] [PubMed] [Google Scholar]

Matsumoto N, Whisnant J, Kurland L, Okazaki H. Natural history of stroke in Rochester, Minnesota 1955-1969. Stroke. 1973;4:2–29. doi: 10.1161/01.str.4.1.20. [DOI] [PubMed] [Google Scholar]

Caplan LR. Stroke: A clinical approach. 3rd ed. Boston: Butterworth-Heinemann; 2000. [Google Scholar]

Mohr JP, Caplan LR, Melski JW, Goldstein RJ, Duncan GW, Kistler JP, et al. The Harvard Cooperative Stroke registry: A prospective study. Neurology. 1978;28:754–62. doi: 10.1212/wnl.28.8.754. [DOI] [PubMed] [Google Scholar]

Cardiogenic brain embolism: The second report of the Cerebral Embolism Task Force. Arch Neurol. 1989;46:727–43. [PubMed] [Google Scholar]

Leary MC, Caplan LR. Cerebrovascular disease and neurologic manifestations of heart disease. In: Fuster V, Alexander RW, O-Rourke RA, Roberts R, King 3rd, et al., editors. Hurst?s the Heart. 12th ed. New York: McGraw-Hill; 2007. [Google Scholar]

Fuster V, Halperin JL. Left ventricular thrombi and cerebral embolism. N Engl J Med. 1989;320:392–4. doi: 10.1056/NEJM198902093200610. [DOI] [PubMed] [Google Scholar]

Wolf PA, Abbot RD, Kannel WB. Atrial fibrillation: A major contributor to stroke in the elderly: The Framingham study. Arch Intern Med. 1987;147:1561–4. [PubMed] [Google Scholar]

Li X, Zhou G, Zhou X, et al. The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: a meta-analysis of randomized controlled trials. J Neurol Sci DOI: 10.1016/j.jns.2013.06.025

Goyal A, Yusuf S. The burden of cardiovascular disease in the Indian subcontinent. Indian J Med Res. 2006;124:235–44.

Lipska K, Sylaja PN, Sarma PS, Thankappan KR, Kutty VR, et al. Risk factors for acute ischaemic stroke in young adults in South India. J Neurol Neurosurg Psychiatry. 2007;78:959–63.

Global Burden of Disease Study 2021 DOI: 10.1016/j.eclinm.2024.102758

Global, regional, and national burden of stroke and its risk factors, 1990–2021. DOI: 10.1016/S14744422(24)003697

Caplan LR. Brain embolism. In: Caplan LR, Hurst JW, Chimowitz MI, editors. Clinical Neurocardiology. New York: Marcel Dekker; 1999. pp. 35–185.

Aring C, Merritt H. Differential diagnosis between cerebral hemorrhage and cerebral thrombosis. Arch Intern Med. 1935;56:435–56.

Whisnant J, Fitzgibbons J, Kurland L, Sayre GP. Natural history of stroke in Rochester, Minnesota 1945-1954. Stroke. 1971;2:11–22.

Matsumoto N, Whisnant J, Kurland L, Okazaki H. Natural history of stroke in Rochester, Minnesota 1955-1969. Stroke. 1973;4:2–29.

Caplan LR. Stroke: A clinical approach. 3rd ed. Boston: Butterworth-Heinemann; 2000.

Mohr JP, Caplan LR, Melski JW, Goldstein RJ, Duncan GW, Kistler JP, et al. The Harvard Cooperative Stroke registry: A prospective study. Neurology. 1978;28:754–62.

Cardiogenic brain embolism: The second report of the Cerebral Embolism Task Force. Arch Neurol. 1989;46:727–43.

Leary MC, Caplan LR. Cerebrovascular disease and neurologic manifestations of heart disease. In: Fuster V, Alexander RW, O’Rourke RA, Roberts R, King 3rd, et al., editors. Hurst’s the Heart. 12th ed. New York: McGraw-Hill; 2007.

Fuster V, Halperin JL. Left ventricular thrombi and cerebral embolism. N Engl J Med. 1989;320:392–4.

Wolf PA, Abbot RD, Kannel WB. Atrial fibrillation: A major contributor to stroke in the elderly: The Framingham study. Arch Intern Med. 1987;147:1561–4.j

Downloads

Published

2026-05-05